Trial Profile
Efficacy and safety of switching from TWIce-daily exenatide to oNce-weekly exenatide in Japanese patients with type 2 diabetes mellitus;Multicenter, Prospective, Single-arm trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2020
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Twin
- 08 Apr 2019 According to UMIN, the date for data entry closure is 2017/07/26, and the date for conclusion of data analysis is 2017/08/15 .
- 08 Apr 2019 Status changed from active, no longer recruiting to discontinued.
- 02 Feb 2017 Status changed from recruiting to active, no longer recruiting.